Insider Selling: Ainos (NASDAQ:AIMD) Major Shareholder Sells 41,000 Shares of Stock

Ainos, Inc. (NASDAQ:AIMD) major shareholder Carbon Nano Technology Taiwan sold 41,000 shares of the company’s stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $2.36, for a total transaction of $96,760.00. Following the completion of the sale, the insider directly owned 948,925 shares in the company, valued at approximately $2,239,463. This represents a 4.14% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Ainos Trading Down 19.0%

Shares of NASDAQ:AIMD traded down $0.60 during trading on Wednesday, reaching $2.56. The stock had a trading volume of 1,873,740 shares, compared to its average volume of 893,030. Ainos, Inc. has a 52 week low of $1.26 and a 52 week high of $4.50. The firm’s fifty day moving average is $1.67 and its 200 day moving average is $1.83. The stock has a market cap of $21.81 million, a price-to-earnings ratio of -0.89 and a beta of 2.29. The company has a debt-to-equity ratio of 1.58, a quick ratio of 0.50 and a current ratio of 0.55.

Ainos (NASDAQ:AIMD) last announced its earnings results on Wednesday, May 13th. The company reported ($0.41) earnings per share for the quarter. Ainos had a negative return on equity of 160.55% and a negative net margin of 11,912.10%.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings raised shares of Ainos from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has a consensus rating of “Sell”.

Institutional Trading of Ainos

Several large investors have recently modified their holdings of AIMD. Mariner LLC acquired a new stake in shares of Ainos during the 4th quarter worth approximately $37,000. Two Sigma Investments LP acquired a new stake in shares of Ainos during the 3rd quarter worth approximately $80,000. DRW Securities LLC grew its position in shares of Ainos by 272.6% during the 4th quarter. DRW Securities LLC now owns 66,211 shares of the company’s stock worth $109,000 after buying an additional 48,439 shares during the period. Finally, Renaissance Technologies LLC grew its position in shares of Ainos by 13.1% during the 4th quarter. Renaissance Technologies LLC now owns 66,300 shares of the company’s stock worth $109,000 after buying an additional 7,700 shares during the period.

About Ainos

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.